Keywords: europe, backs, merck, bisoprolol, chf, kgaa, received

Europe backs Merck's bisoprolol for CHF

Article | 14 October 1999

Print This

Merck KGaA has received positive opinions from the European regulatoryauthorities for use of its beta blocker Concor/Ziac (bisoprolol) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in